-=Doximity (DOCS) reported earnings on Tue 8 Feb 22 (a/h)

• Reported upside Q3 results. Issued upside guidance for FY23 revs, calling for growth of approx. +33% excluding the acquisition of on-call physician scheduling site Amion, a transaction that co announced alongside its earnings press. At two-month highs. 

Doximity beats by $0.17, beats on revs; guides MarQ revs in-line; guides FY23 revs above consensus

• Reports Q3 (Dec) earnings of $0.29 per share, excluding non-recurring items, $0.17 better than the S&P Capital IQ Consensus of $0.12; revenues rose 66.7% year/year to $97.88 mln vs the $86.27 mln S&P Capital IQ Consensus.
• Co issues in-line guidance for Q4 (Mar), sees Q4 revs of $89-90 mln vs. $89.22 mln S&P Capital IQ Consensus.
• Co issues upside guidance for FY23, sees FY23 revs of $450 mln vs. $425.37 mln S&P Capital IQ Consensus.